Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease

Monday, November 23, 2020

RedHill Biopharma Ltd a specialty biopharmaceutical company announced that it has initiated its Phase study to evaluate the safety and efficacy of RHB as a potential firstline standalone oral treatment of pulmonary nontuberculous mycobacteria NTM di...

Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement

Saturday, November 21, 2020

Eli Lilly and Company and Precision BioSciences Incannounced a research collaboration and exclusive license agreement to utilize Precisions proprietary ARCUS genome editing platform for the research and development of potential in vivo therapies for...

Immunomic Therapeutics and CoImmune Therapeutics Enter into Partnership to Manufacture ITI-1020, a Novel Experimental Cell Therapy for Glioblastoma

Friday, November 20, 2020

Immunomic Therapeutics Inc ITI a privatelyheld clinicalstage biotechnology company pioneering the study of nucleic acid immunotherapy platforms and CoImmune Inc CoImmune a privately held clinicalstage immunooncology company developing cellbased thera...

Pfizer and LianBio Announce Strategic Collaboration to Expand Development of Novel Therapeutics in Greater China

Friday, November 20, 2020

Pfizer Inc and LianBio announced that they have entered into a collaboration aimed at developing and commercializing transformative pharmaceutical products in Greater China LianBio founded by Perceptive Advisors forged a collaboration with Pfizer to...

Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics

Thursday, November 19, 2020

Revive Therapeutics Ltd a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders is pleased to announce it has entered into an exclusive research collaboration agreement with Pharm...

InMed Pharmaceuticals and BayMedica Announce Collaboration for Manufacturing and Testing of Novel Cannabinoid Therapeutics

Thursday, November 19, 2020

InMed Pharmaceuticals Inc a clinicalstage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol CBN and BayMedica Inc a company specializing in the...

Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases

Wednesday, November 18, 2020

Lead Pharma a clinical stage pharmaceutical company designing and developing innovative medicines for the treatment of immune mediated diseases and cancer today announced that it has entered into a collaboration and license agreement with Roche to de...

Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments

Wednesday, November 18, 2020

Samsung Biologics partnership with Eli Lilly and Company is expected to greatly accelerate the global supply for Lillys COVID antibody therapies through a longterm manufacturing agreement with the ultimate goal of making antibody treatments more glob...

Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators

Tuesday, November 17, 2020

Assembly Biosciences Inc and Door Pharmaceuticals LLC announced that the companies have signed an exclusive twoyear collaboration and option agreement focused on the development of a novel class of hepatitis B virus HBV core protein modulators

Aeterna Zentaris Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin

Tuesday, November 17, 2020

Aeterna Zentaris Inc a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests announced that through a whollyowned subsdiary it has entered into an amendment the Amendment of its existing License Agreemen...